You have read all your free articles, to continue reading subscribe to read the rest of this content.
Omnio has developed a drug candidate based on the protein plasminogen that can counteract tooth loss. Thanks to the funding the company may now move forward even faster, states the CEO, Patric Stafshede Tooth loss Tooth loss can be caused by periodontitis, an infectious disease that causes teetAlready a subscriber…
HiloProbe has attracted new investment capital after developing a diagnostic and prognostic product for colon and rectal cancer. HiloProbe has developed a product called ColoNode that is used for the diagnosis and prognosis of colon and rectal cancer by identifying tumor cells in lymph nodes and Already a subscriber Login…
Sprung from the University of Linköping’s world-renowned Center for Medical Image Science and Visualization and the departments of Biomedical Engineering and Medicine and Health, AMRA has become an international digital health company. Intended to aid in disease prediction, AMRA’s body compoAlready a subscriber Login You have read all your free…
Mendus has entered into a manufacturing alliance with NorthX Biologics and has announced a directed share issue and a fully secured rights issue of units totaling approximately 317 million SEK in financing. In the alliance with NorthX, Mendus and NorthX will co-establish cell therapy manufacturinAlready a subscriber Login You have…
